Navigation Links
EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in,Preclinical Models

Tumor Inhibition Demonstrated in Lung and Colorectal Cancers

ROCKVILLE, Md., April 16, 2007 /PRNewswire-FirstCall/ -- EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced the presentation of results for its preclinical tubulin inhibitor compounds. The data were presented by EntreMed scientists at the American Association for Cancer Research (AACR) Annual Meeting in Los Angeles, California.

Results of the studies presented at the AACR meeting demonstrated a potent, dose-dependent inhibition of tumor growth following the administration of ENMD-1420 (previously CC-5079) in two distinct preclinical models of metastatic lung and colorectal carcinoma. At maximally tolerated doses, tumor growth inhibition ranged from 80-90%. ENMD-1420 can exist in two chemical configurations termed the Z or E isomer. In vivo studies with each configuration further demonstrated the Z isomer (ENMD-1427) to be significantly more potent than the E isomer (ENMD-1916) for antitumor activity.

Part of the mechanism by which ENMD-1420 exerted an antitumor effect involved the inhibition of angiogenesis, in addition to its antiproliferative activity. In vivo angiogenesis assays showed that the administration of ENMD- 1420 at maximally tolerated doses led to the disruption of established blood vessels. Previous studies showed that ENMD-1420 inhibits tubulin polymerization and TNF-alpha production, contributing to its antiproliferative activity through apoptosis. Collectively, these data suggest that both ENMD- 1420 and its Z isomer have potent antitumor and antiangiogenic activity. Furthermore, a synthetic strategy targeting a particular isomer can be used to optimize antitumor and antiangiogenic activity for purposes of lead compound identification.

Carolyn F. Sidor, M.D., M.B.A., EntreMed Vice President and Chief Medical Officer, st
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
2. Phase 2 Results for EntreMeds Panzem NCD Brain Cancer Study Presented at ASCO
3. EntreMeds Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models
4. EntreMed Presents Preclinical Data for MKC-1 in Hematological Cancers
5. EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting
6. EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
9. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
10. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
11. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
Post Your Comments:
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 /PRNewswire/ ... report is available in its catalogue: ... U.S. IVD Industry http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html ... Care Act" (H.R. 3590) is complex legislation that ... many of its provisions are beginning to take ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportbuyer.com has added ... Defibrillators Industry https://www.reportbuyer.com/product/98394/Global-Cardiac-Defibrillators-Industry.html ... in US$ Million by the following Product Segments: Implantable/Internal ... comprehensive analytics for the US, Canada ... , Asia-Pacific , ...
(Date:8/20/2014)... New York , August 20, 2014 ... a new market report titled "Monochloroacetic Acid (MCA) Market ... Applications - Global Industry Analysis, Size, Share, Growth, Trends ... market was valued at USD 817.1 million in 2013 ... 2020, growing at a CAGR of 3.6% during the ...
Breaking Medicine Technology:The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Global Cardiac Defibrillators Industry 2Global Cardiac Defibrillators Industry 3Global Cardiac Defibrillators Industry 4Global Cardiac Defibrillators Industry 5Global Cardiac Defibrillators Industry 6Global Cardiac Defibrillators Industry 7Global Cardiac Defibrillators Industry 8Global Cardiac Defibrillators Industry 9Global Cardiac Defibrillators Industry 10Global Cardiac Defibrillators Industry 11Global Cardiac Defibrillators Industry 12Global Cardiac Defibrillators Industry 13Global Cardiac Defibrillators Industry 14Global Cardiac Defibrillators Industry 15Global Cardiac Defibrillators Industry 16Global Cardiac Defibrillators Industry 17Global Cardiac Defibrillators Industry 18Global Cardiac Defibrillators Industry 19Global Cardiac Defibrillators Industry 20Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4
... DURECT Corporation (Nasdaq: DRRX ) announced ... Executive Vice President, Corporate Strategy has resigned effective June ... DURECT have entered into a consulting agreement through December ... "We appreciate all of Joe,s efforts over ...
... Inc., a leading global provider of medical imaging software, ... MIM Software is currently demonstrating MIMcloud 2.0 at their ... D.C. MIMcloud provides an easy, convenient, and secure way ... "MIMcloud combined with Mobile MIM makes remote imaging ...
Cached Medicine Technology:DURECT Announces Resignation of Chief Medical Officer 2MIMcloud 2.0, the Next Generation of Cloud Computing for Medical Images, Shown at SIIM 2011 2
(Date:8/20/2014)... York, NY (PRWEB) August 20, 2014 Ticket ... Tennis Championship tickets in NYC. In just a week, ... Billie Jean King Tennis Center. The event was originally founded in ... 2013 event, Rafael Nadal was forced to withdrawal from the event ... the 2014 women’s tournament and will return to New York City ...
(Date:8/20/2014)... Less than 42 percent of women underwent breast ... factors associated with foregoing reconstruction included being black, ... , Author: Monica Morrow, M.D., of the Memorial ... , Background: The Women,s Health and Cancer Rights ... reconstruction following a mastectomy. Still, most women who ...
(Date:8/20/2014)... Pigs, hearts transplanted into baboons survived for more than ... achieved, researchers report. The work is part of ... shorten transplant waiting lists. In this study, scientists ... The genetic engineering and new methods of suppressing the ... to survive for more than a year. The ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. ... has long been an option, but a new study shows ... "The most common reasons women didn,t undergo reconstruction was that ... surgery or they were focused on their cancer treatment," said ... Memorial Sloan Kettering Cancer Center, in New York City. ...
(Date:8/20/2014)... spawning grounds through fast-moving waters may be at risk, ... , When salmon encounter turbulent, fast-moving water such ... must move upstream using a behaviour known as "burst ... "Days after sockeye passed through extremely fast-moving water, we ... from their spawning grounds," said Nicholas Burnett, a research ...
Breaking Medicine News(10 mins):Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:Pigs' Hearts Beat for a Year in Baboons' Abdomens 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 3Health News:Salmon forced to 'sprint' less likely to survive migration 2
... satisfaction survey shows health improvements, disease ... benefits of plan -, ATLANTA, Nov. 12 One ... 92 percent of members of Care,Improvement Plus feel their health ... satisfaction of the plan,s southeast regional,membership. Of those who feel ...
... management software MCT-Diabetes, has announced that nationally-recognized diabetes specialist Dr. ... a regularly scheduled online column to the MyCareTeam diabetes community. ... ... 12, 2008 -- MyCareTeam, Inc., a leading vendor of Internet-based ...
... 12 Centocor, Inc. announced today,the launch ... resource designed to facilitate more-informed conversations,between U.S. ... and safety of,REMICADE(R) (infliximab)., This interactive ... three,years and the first in its therapeutic ...
... ... volunteer, PITTSBURGH, ... in Pennsylvania to support programs,with which Highmark employees volunteer. Grants were ... education,and raise funds to provide access to health care services., ...
... ForHealth Technologies, IntelliFill i.v. robot to ... reduces errors and ... ForHealth Technologies,Inc., a pioneer in medication error reduction and ... its robotic I.V. dose,preparation system, IntelliFill i.v.(TM), by the ...
... shows health improvements, disease ... plan -, ST. LOUIS, Nov. 12 One year ... of members of Care,Improvement Plus feel their health has maintained ... the plan,s south central,regional membership. Of those who feel health ...
Cached Medicine News:Health News:Georgia and South Carolina Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan 2Health News:Nationally Recognized Diabetes Specialist Dr. Steven Edelman to Provide Educational Articles on Diabetes to MyCareTeam's Website Community 2Health News:Nationally Recognized Diabetes Specialist Dr. Steven Edelman to Provide Educational Articles on Diabetes to MyCareTeam's Website Community 3Health News:MEDVERSATION(TM) Website Launched by Centocor to Facilitate Physician-Patient Dialogue About Drug Benefits and Risks 2Health News:MEDVERSATION(TM) Website Launched by Centocor to Facilitate Physician-Patient Dialogue About Drug Benefits and Risks 3Health News:MEDVERSATION(TM) Website Launched by Centocor to Facilitate Physician-Patient Dialogue About Drug Benefits and Risks 4Health News:MEDVERSATION(TM) Website Launched by Centocor to Facilitate Physician-Patient Dialogue About Drug Benefits and Risks 5Health News:MEDVERSATION(TM) Website Launched by Centocor to Facilitate Physician-Patient Dialogue About Drug Benefits and Risks 6Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 2Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 3Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 4Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 5Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 6Health News:Alegent Health System Automates I.V. Preparation to Enhance Patient Safety 2Health News:Arkansas and Missouri Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan 2
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
... The Self-Cath Closed System is a ... method for safe, simple catheterization designed ... tract infections. It includes a ... The new EasyOff tear tab makes ...
... Self-Cath family of 100% ... a variety of options ... Each catheter is made ... PVC and has smooth ...
... The Self-Cath family ... offers patients a variety ... self-catheterization. Each catheter ... medical grade PVC and ...
Medicine Products: